Brief: Venus Remedies Secures Marketing Authorisation From UK MHRA For Cisplatin
25/04/2023 06:47
April 25 (Reuters) - Venus Remedies Ltd VENR.NS :
* SECURES MARKETING AUTHORISATION FROM UK MHRA FOR CISPLATIN
Source text for Eikon: ID:nBSEnNGBS
Further company coverage: VENR.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Venus Remedies
See all newsBrief: Venus Remedies Sept-Quarter Consol Net Profit 256.5 Million Rupees
Brief: Venus Remedies Secured Five Marketing Authorisations Across Kazakhstan, Peru, Kuwait And Argentina
India's Venus Remedies rises after quarterly profit more than doubles
Brief: Venus Remedies June-Quarter Consol Net Profit 229.7 Million Rupees
India raises price cap on cancer drugs to tackle shortage